CS
NEO icon

Candriam SCA’s NeoGenomics NEO Stock Holding History

Candriam SCA’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-467,026
Closed -$6.89M – 698
2024
Q3 		$6.89M Sell
467,026
-20,000
-4% -$313K 0.04% 312
2024
Q2 		$6.75M Buy
487,026
+112,009
+30% +$1.59M 0.04% 298
2024
Q1 		$5.9M Buy
375,017
+170,010
+83% +$2.62M 0.04% 318
2023
Q4 		$3.32M Buy
+205,007
New +$3.35M 0.02% 398
2023
Q2 		– Sell
-25,851
Closed -$414K – 818
2023
Q1 		$414K Sell
25,851
-51,028
-66% -$727K ﹤0.01% 815
2022
Q4 		$710K Sell
76,879
-21,437
-22% -$200K ﹤0.01% 762
2022
Q3 		$847K Buy
+98,316
New +$976K 0.01% 745
2022
Q1 		– Sell
-268,194
Closed -$9.15M – 834
2021
Q4 		$9.15M Buy
268,194
+8,074
+3% +$316K 0.06% 273
2021
Q3 		$12.5M Buy
260,120
+72,788
+39% +$3.37M 0.09% 237
2021
Q2 		$8.46M Sell
187,332
-109,187
-37% -$4.84M 0.06% 310
2021
Q1 		$15.3M Sell
296,519
-9
-0% -$469 0.13% 180
2020
Q4 		$16M Buy
296,528
+261,545
+748% +$11.8M 0.13% 182
2020
Q3 		$1.29M Sell
34,983
-527,115
-94% -$19.6M 0.01% 573
2020
Q2 		$17.4M Buy
562,098
+95,433
+20% +$2.64M 0.18% 137
2020
Q1 		$13.3M Buy
466,665
+81
+0% +$2.43K 0.15% 162
2019
Q4 		$13.6M Buy
466,584
+206,383
+79% +$4.91M 0.15% 162
2019
Q3 		$4.97M Buy
260,201
+84,000
+48% +$1.97M 0.07% 320
2019
Q2 		$3.85M Buy
176,201
+43,000
+32% +$944K 0.05% 388
2019
Q1 		$2.73M Buy
+133,201
New +$2.31M 0.03% 434

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Candriam SCA's NEO Position: Q4 2024 in Review

Candriam SCA sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 467,026 shares — an estimated $6.89M sold.

Candriam SCA first reported a position in NEO in Q1 2019 and held it in 19 quarters. The position peaked at $17.4M in Q2 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

  • Candriam SCA reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
  • Candriam SCA sold 467,026 NeoGenomics shares in Q4 2024, an estimated $6.89M.
  • Candriam SCA first reported a position in NeoGenomics in Q1 2019 and held it in 19 quarters.
  • Candriam SCA's NeoGenomics position peaked at $17.4M in Q2 2020.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on Candriam SCA's 13F filing for Q4 2024, filed 7 Feb 2025.